370 related articles for article (PubMed ID: 1303164)
1. Changes in acetylcholinesterase and butyrylcholinesterase in Alzheimer's disease resemble embryonic development--a study of molecular forms.
Arendt T; Brückner MK; Lange M; Bigl V
Neurochem Int; 1992 Oct; 21(3):381-96. PubMed ID: 1303164
[TBL] [Abstract][Full Text] [Related]
2. Molecular forms of acetylcholinesterase and butyrylcholinesterase in human plasma and cerebrospinal fluid.
Atack JR; Perry EK; Bonham JR; Perry RH
J Neurochem; 1987 Jun; 48(6):1845-50. PubMed ID: 3572402
[TBL] [Abstract][Full Text] [Related]
3. Molecular forms of acetylcholinesterase and butyrylcholinesterase in the aged human central nervous system.
Atack JR; Perry EK; Bonham JR; Candy JM; Perry RH
J Neurochem; 1986 Jul; 47(1):263-77. PubMed ID: 3711902
[TBL] [Abstract][Full Text] [Related]
4. Neurological cholinesterases in the normal brain and in Alzheimer's disease: relationship to plaques, tangles, and patterns of selective vulnerability.
Wright CI; Geula C; Mesulam MM
Ann Neurol; 1993 Sep; 34(3):373-84. PubMed ID: 8363355
[TBL] [Abstract][Full Text] [Related]
5. Potencies and selectivities of inhibitors of acetylcholinesterase and its molecular forms in normal and Alzheimer's disease brain.
Rakonczay Z
Acta Biol Hung; 2003; 54(2):183-9. PubMed ID: 14535624
[TBL] [Abstract][Full Text] [Related]
6. In vitro and in silico analysis of novel astaxanthin-s-allyl cysteine as an inhibitor of butyrylcholinesterase and various globular forms of acetylcholinesterases.
Sakayanathan P; Loganathan C; Kandasamy S; Ramanna RV; Poomani K; Thayumanavan P
Int J Biol Macromol; 2019 Nov; 140():1147-1157. PubMed ID: 31442505
[TBL] [Abstract][Full Text] [Related]
7. Molecular forms of acetylcholinesterases in Alzheimer's disease.
Younkin SG; Goodridge B; Katz J; Lockett G; Nafziger D; Usiak MF; Younkin LH
Fed Proc; 1986 Dec; 45(13):2982-8. PubMed ID: 2430839
[TBL] [Abstract][Full Text] [Related]
8. Molecular forms of acetylcholinesterase in subcortical areas of normal and Alzheimer disease brain.
Siek GC; Katz LS; Fishman EB; Korosi TS; Marquis JK
Biol Psychiatry; 1990 Mar; 27(6):573-80. PubMed ID: 2322617
[TBL] [Abstract][Full Text] [Related]
9. Quantitative development and molecular forms of acetyl- and butyrylcholinesterase during morphogenesis and synaptogenesis of chick brain and retina.
Layer PG; Alber R; Sporns O
J Neurochem; 1987 Jul; 49(1):175-82. PubMed ID: 3585328
[TBL] [Abstract][Full Text] [Related]
10. Activities and kinetic properties of lumbar cerebrospinal fluid cholinesterases in relation to clinical diagnosis, severity, and progression of Alzheimer's disease.
Huff FJ; Reiter CT; Protetch J
Can J Neurol Sci; 1989 Nov; 16(4):406-10. PubMed ID: 2804802
[TBL] [Abstract][Full Text] [Related]
11. Peripheral cholinergic disturbances in Alzheimer's disease.
Rakonczay Z; Horváth Z; Juhász A; Kálmán J
Chem Biol Interact; 2005 Dec; 157-158():233-8. PubMed ID: 16243305
[TBL] [Abstract][Full Text] [Related]
12. Acetylcholinesterase and butyrylcholinesterase in frontal cortex and cerebrospinal fluid of demented and non-demented patients with Parkinson's disease.
Ruberg M; Rieger F; Villageois A; Bonnet AM; Agid Y
Brain Res; 1986 Jan; 362(1):83-91. PubMed ID: 3942870
[TBL] [Abstract][Full Text] [Related]
13. Differential laminar distribution of acetylcholinesterase and butyrylcholinesterase containing tangles in the cerebral cortex of Alzheimer's disease.
Coleman AE; Geula C; Price BH; Mesulam MM
Brain Res; 1992 Nov; 596(1-2):340-4. PubMed ID: 1467998
[TBL] [Abstract][Full Text] [Related]
14. Cholinesterases in normal and Alzheimer's disease primary olfactory gyrus.
Hamodat H; Cash MK; Fisk JD; Darvesh S
Neuropathol Appl Neurobiol; 2017 Dec; 43(7):571-583. PubMed ID: 28644906
[TBL] [Abstract][Full Text] [Related]
15. Molecular forms of butyrylcholinesterase in the human neocortex during development and degeneration of the cortical cholinergic system.
Atack JR; Perry EK; Bonham JR; Candy JM; Perry RH
J Neurochem; 1987 Jun; 48(6):1687-92. PubMed ID: 3572398
[TBL] [Abstract][Full Text] [Related]
16. Acetylcholinesterase and butyrylcholinesterase activities in cerebrospinal fluid from different levels of the neuraxis of patients with dementia of the Alzheimer type.
Appleyard ME; McDonald B
J Neurol Neurosurg Psychiatry; 1992 Nov; 55(11):1074-8. PubMed ID: 1469405
[TBL] [Abstract][Full Text] [Related]
17. Acetylcholinesterase and butyrylcholinesterase activity in the cerebrospinal fluid of patients with neurodegenerative diseases involving cholinergic systems.
Ruberg M; Villageois A; Bonnet AM; Pillon B; Rieger F; Agid Y
J Neurol Neurosurg Psychiatry; 1987 May; 50(5):538-43. PubMed ID: 2953866
[TBL] [Abstract][Full Text] [Related]
18. Acetylcholinesterase is increased in the brains of transgenic mice expressing the C-terminal fragment (CT100) of the beta-amyloid protein precursor of Alzheimer's disease.
Sberna G; Sáez-Valero J; Li QX; Czech C; Beyreuther K; Masters CL; McLean CA; Small DH
J Neurochem; 1998 Aug; 71(2):723-31. PubMed ID: 9681463
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
